Non-linear associations between red blood cell distribution width/serum albumin ratio with diabetic kidney disease: results from two nationwide studies in the United States and China

Read full text Summarise with VIRAT
Authors: Yao Cheng, Pan Yan, Hongyu Yue, Chongyang Han, Baodong Wang
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This study aimed to better investigate the association between the red blood cell distribution width to serum albumin ratio (RA) and diabetic kidney disease (DKD) by utilizing data from the United States National Health and Nutrition Examination Survey (NHANES) and clinical data from Shanxi Provincial People’s Hospital Affiliated to Shanxi Medical University, China (SMU). A total of 3,734 and 393 participants were selected from NHANES (2011–2018) and SMU, respectively. The primary diagnosis of DKD was defined as eGFR < 60 mL/min/1.73 m2 or urinary albumin-creatinine-ratio (ACR) ≥ 30 mg/g. Multivariable logistic regression, restricted cubic spline (RCS) analysis, propensity score matching (PSM), and Kaplan-Meier survival analysis were used to evaluate the relationship between RA levels and DKD. The prevalence of DKD was estimated to be 40.38% in NHANES and 54.96% in SMU among diabetic patients. After full adjustment, higher RA levels were significantly associated with increased DKD risk in both cohorts (NHANES: OR = 1.46, 95% CI: 1.13–1.87; SMU: OR = 1.27, 95% CI: 1.01–1.60). RCS analysis revealed a nonlinear relationship between RA and all-cause mortality in DKD patients (P for nonlinearity < 0.001), with an optimal cutoff of 3.33dL/g. Patients with RA ≥ 3.33dL/g had significantly lower cumulative survival rates (log-rank P < 0.05). Subgroup analyses showed consistent associations across most strata. Higher RA level is independently associated with increased risk and poor prognosis of DKD in diabetic patients. An RA cutoff of 3.33dL/g may serve as a useful clinical marker for risk stratification.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Diabetes Cardiovascular Risks and Lipoproteins Dialysis and Renal Disease Management

Publication details

Journal / source
Scientific Reports
Volume
16
Issue
1
Pages
10639
Publication date
30 March 2026
Language
EN